News

China Law and Practice11d
In the News: Pharma Data Protection Rules; Facial Recognition Restrictions; and UBS Fully Owns Its Chinese Operations
China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate ...
China Law and Practice13d
Illumina’s Inclusion in China’s Unreliable Entity List: Patent Wars, Geopolitical Risks, and Compliance Strategies
Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s ...
China Law and Practice4d
In the News: China Restricts Outbound Investments; Shenzhen Foreign Hospitals; and US Companies Survey
China to block Chinese firms from investing in the U.S. amid tariff war; Shenzhen launches incentives for foreign-owned ...
China Law and Practice6d
Legislation roundup: Cybersecurity Law amendment draft, pharma clinical data and facial recognition
Cybersecurity Law amendment draft imposes heavier penalties. China proposes different data protection periods for three categories of drugs. Facial information collection requires obligations of ...
China Law and Practice7d
State Council, Provisions for Handling Foreign-Related Intellectual Property Disputes
State Council restricts provision of evidence outside of mainland China for IP cases / CLP Reference: 5100/25.03.13 ; Promulgated: 2025-03-13 ; Effective: 2025-05-01 ...
chinalawandpractice.com19d
Legislation roundup: Anti-Foreign Sanctions Law, antitrust penalties, and foreign-related IP disputes
State Council, Provisions for Implementation of the «PRC Anti-Foreign Sanctions Law» 国务院实施〈中华人民共和国反外国制裁法〉的规定 Where ...
chinalawandpractice.com1mon
In the News: HKEX Rebounds; China Launches New Technology Fund; and New Zealand T&G Wins Plant Variety Case
Hong Kong stock market rebounds when Chinese government halts Swiss listings; China backs AI with government investment fund; and China’s Supreme People’s Court further protects intellectual property ...